Propanc Biopharma enters $112,350 convertible note at 22% interest with 1800 Diagonal Lending

Propanc Biopharma, Inc.

Issued $112,350 convertible promissory note to 1800 Diagonal Lending LLC at a 22% annual interest rate.
Conversion price is 75% of average lowest trading price over 10 days prior to conversion, with 4.99% beneficial ownership cap.
Maturity date April 30, 2026; company can prepay at 120% premium within 90 days, 125% from 91-180 days.
Proceeds from $107,000 purchase price (after $5,350 original issue discount) used for general working capital.
Events of default include failure to pay, failure to issue conversion shares, and loss of OTC listing.

item 1.01item 2.03item 3.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.